Nikki Hancocks

Aging research has never been more relevant, with an aging population and highly stretched healthcare consumer interest and commercial opportunity in this space are greater than ever, yet fundamental questions remain unanswered and investment in research is scarce, according to the British Society for Research on Ageing (BSRA).

The extraordinary individuality of the human gut microbiome presents one of the greatest challenges for personalized nutrition, and the solution lies in large-scale research.

US-based biotech firm CoreFX LLC has expanded into Europe with a new headquarters in Ireland, in collaboration with Teagasc Food Research Centre, Moorepark and supported by Enterprise Ireland.

From the warming climate and extreme weather to geopolitical tensions and consumer expectations, the supplements industry is facing mounting pressure to decouple production from agriculture in order to build more sustainable supply chains.

Supplementation with a calcium-rich byproduct of whey protein production for 12 months supports the maintenance of bone mineral density in postmenopausal women, according to a new clinical study.

In an increasingly saturated hormonal health market, brands are working to deliver a unique selling proposition by taking a deeper look at how hormones are impacted across life stages and the science-backed nutrition interventions that can deliver a sense of balance.

Nutritional modulation of gut microbiota must account for a complex web of factors, including age, genetics, lifestyle, environment and, crucially, the composition and functions of the existing microbiome.

EFSA has rejected Mimer Medical’s health claim application for its branded spinach extract, stating it did not provide evidence of a link between prolonged satiety and a beneficial physiological effect.

The European Patent Court has provisionally banned US-brand Pendulum and several online retailers from selling a probiotic for the prevention or treatment of insulin resistance following a claim of infringement from Caelus Life Sciences.

The GLP-1 phenomenon is bringing the market to the sports and active nutrition category and these consumers may be more supplement focused that the industry thinks.